Indian pharmaceutical market touches 1,00,000 crore mark
Advertisement
Advertisement
This could be good news for the well-wishers of the The study has shown that the golden landmark was touched in November, and the figure was calculated on the basis of Moving Annual Total (MAT).
In the report, it is said that three-fourth of the market share was taken over by Indian companies during the month of November.
The Indian pharmaceutical market has grown by an average of 12% over the last three years. In this, drugs that treat infections, heart ailments and patients with gastro-intestinal issues covered almost 38% of the share.
As per the report, in November, Indian market was valued at Rs 1,00,115 crore, of which the retail sector was valued at Rs 84,279 crore.
Advertisement
Talking of companies, Sun Pharma held its top position with a market share of 8%, followed by Abbott that has a share of 6.1%. Cipla isn’t too far behind, with 5.4% market share, and has grown higher than its top peers with a growth of 16% during the month.
In brands, however, it was Mixtard, the popular insulin marketed by Abbott, that retained its first position as the largest brand for the month. It was followed by the cough syrup brand Corex (Pfizer) and Glycomet-gp, a diabetes brand of USV.
Image source
Advertisement
- Sustainable Energy Efficiency
- BenQ Zowie XL2546X review – Monitor for the serious gamers
- 9 health benefits of drinking sugarcane juice in summer
- 10 benefits of incorporating almond oil into your daily diet
- From heart health to detoxification: 10 reasons to eat beetroot
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market